TELA Bio, Inc. (TELA) Misses Q3 EPS by 3c

TELA Bio, Inc. (NASDAQ: TELA) reported Q3 EPS of ($0.19), $0.03 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $20.7 million versus the consensus estimate of $22.23 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• SpaceX (SPCX) call put ratio 1.5 calls to 1 put as share price up 1.4%
• Morgan Stanley course-corrects their semiconductor equipment outlook on demand